Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;31(6):3672-3674.
doi: 10.1245/s10434-024-15111-4. Epub 2024 Feb 28.

SOUND (Sentinel Node Versus Observation After Axillary Ultrasound) Trial: Are We Ready to Change the Tune of Our Breast Cancer Practice?

James W Jakub  1 , Pooja Advani  2 , Robert Maxwell  3 , Laura Vallow  4 , Santo Maimone  3 , Sarah McLaughlin  5
Affiliations

SOUND (Sentinel Node Versus Observation After Axillary Ultrasound) Trial: Are We Ready to Change the Tune of Our Breast Cancer Practice?

James W Jakub et al. Ann Surg Oncol. 2024 Jun.
No abstract available

PubMed Disclaimer

References

    1. Gentilini OD, Botteri E, Sangalli C, Galimberti V, et al. Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial. JAMA Oncol. 2023;9(11):1557–64. https://doi.org/10.1001/jamaoncol.2023.3759 . - DOI - PubMed - PMC
    1. Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15:13. - DOI
    1. Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of surgeons oncology group Z0011 randomized trial. Ann Surg. 2010;252(3):426–32. https://doi.org/10.1097/SLA.0b013e3181f08f32 . - DOI - PubMed
    1. Kalinsky K, Barlow WE, Gralow JR, et al. 21-gene assay to inform chemotherapy benefit in node-positive breast cancer. N Engl J Med. 2021;385(25):2336–47. https://doi.org/10.1056/NEJMoa2108873 . - DOI - PubMed - PMC
    1. Johnston SRD, Toi M, O’Shaughnessy J, et al. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial. Lancet Oncol. 2023;24(1):77. - DOI - PubMed

LinkOut - more resources